HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Bonifati Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

4/2011High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer.
5/2010Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Bonifati Research Topics

Disease

8Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 05/2006
4Psoriatic Arthritis
11/2020 - 05/2010
2Necrosis
03/2015 - 06/2010
2Neoplasms (Cancer)
12/2013 - 01/2012
1Arthritis (Polyarthritis)
03/2015
1Disease Progression
01/2014
1Inflammation (Inflammations)
05/2012
1Oligodendroglioma
01/2012
1Glioma (Gliomas)
01/2012
1Tuberculosis (Tuberculoses)
04/2011
1Hepatitis B
06/2010
1Sarcoidosis (Schaumann Disease)
05/2010
1Pulmonary Sarcoidosis
05/2010
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2006
1Skin Diseases (Skin Disease)
05/2006
1Peritonitis
01/2006
1Infections
01/2006
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
11/2005
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
11/2005
1Blister (Bulla)
11/2005

Drug/Important Bio-Agent (IBA)

3Infliximab (Remicade)FDA Link
01/2014 - 11/2005
2Biological ProductsIBA
04/2022 - 03/2015
2Etanercept (Enbrel)FDA Link
11/2020 - 01/2014
2Pharmaceutical PreparationsIBA
11/2020 - 01/2012
2CytokinesIBA
04/2011 - 11/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2011 - 05/2010
1Messenger RNA (mRNA)IBA
10/2022
1COVID-19 VaccinesIBA
10/2022
1BNT162 VaccineIBA
04/2022
1VaccinesIBA
04/2022
1etanercept biosimilar SB4IBA
11/2020
1Ustekinumab (CNTO 1275)FDA Link
03/2015
1Adalimumab (Humira)FDA Link
01/2014
1Interleukin-22 (IL-22)IBA
01/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1Epidermal Growth Factor (EGF)IBA
12/2013
1ametantrone (HAQ)IBA
05/2012
1Bevacizumab (Avastin)FDA Link
01/2012
1Antineoplastic Agents (Antineoplastics)IBA
01/2012
1AntigensIBA
04/2011
1Angiotensin Receptor AntagonistsIBA
10/2006
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2006
1ORALIT (ORS)IBA
05/2006
1Anti-Bacterial Agents (Antibiotics)IBA
01/2006
1Anti-Infective Agents (Microbicides)IBA
01/2006
1Mupirocin (Bactroban)FDA LinkGeneric
01/2006

Therapy/Procedure

3Therapeutics
06/2010 - 11/2005
2Biological Therapy
03/2015 - 04/2011
1Peritoneal Dialysis
01/2006
1Catheters
01/2006